Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

NCT07592585 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: VC005
DRUG: VC005 Placebo

Sponsor

Jiangsu vcare pharmaceutical technology co., LTD